↓ Skip to main content

The PI3K signaling pathway as a pharmacological target in Autism related disorders and Schizophrenia

Overview of attention for article published in Molecular and Cellular Therapies, February 2016
Altmetric Badge

Mentioned by

twitter
2 X users

Citations

dimensions_citation
54 Dimensions

Readers on

mendeley
109 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
The PI3K signaling pathway as a pharmacological target in Autism related disorders and Schizophrenia
Published in
Molecular and Cellular Therapies, February 2016
DOI 10.1186/s40591-016-0047-9
Pubmed ID
Authors

Lilian Enriquez-Barreto, Miguel Morales

Abstract

This review is focused in PI3K's involvement in two widespread mental disorders: Autism and Schizophrenia. A large body of evidence points to synaptic dysfunction as a cause of these diseases, either during the initial phases of brain synaptic circuit's development or later modulating synaptic function and plasticity. Autism related disorders and Schizophrenia are complex genetic conditions in which the identification of gene markers has proved difficult, although the existence of single-gene mutations with a high prevalence in both diseases offers insight into the role of the PI3K signaling pathway. In the brain, components of the PI3K pathway regulate synaptic formation and plasticity; thus, disruption of this pathway leads to synapse dysfunction and pathological behaviors. Here, we recapitulate recent evidences that demonstrate the imbalance of several PI3K elements as leading causes of Autism and Schizophrenia, together with the plausible new pharmacological paths targeting this signaling pathway.

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 109 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 109 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 24 22%
Researcher 18 17%
Student > Master 13 12%
Student > Bachelor 13 12%
Student > Doctoral Student 10 9%
Other 8 7%
Unknown 23 21%
Readers by discipline Count As %
Neuroscience 24 22%
Biochemistry, Genetics and Molecular Biology 23 21%
Agricultural and Biological Sciences 17 16%
Medicine and Dentistry 8 7%
Computer Science 2 2%
Other 10 9%
Unknown 25 23%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 February 2024.
All research outputs
#20,723,696
of 25,457,297 outputs
Outputs from Molecular and Cellular Therapies
#30
of 36 outputs
Outputs of similar age
#304,189
of 410,507 outputs
Outputs of similar age from Molecular and Cellular Therapies
#3
of 3 outputs
Altmetric has tracked 25,457,297 research outputs across all sources so far. This one is in the 10th percentile – i.e., 10% of other outputs scored the same or lower than it.
So far Altmetric has tracked 36 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 15.6. This one scored the same or higher as 6 of them.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 410,507 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 14th percentile – i.e., 14% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 3 others from the same source and published within six weeks on either side of this one.